Clinical Trials Logo

Conjunctivitis clinical trials

View clinical trials related to Conjunctivitis.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT03862053 Withdrawn - Clinical trials for Allergic Conjunctivitis

Manuka Eye Droops for Treatment of Allergy

Start date: January 1, 2020
Phase: Phase 4
Study type: Interventional

Manuka honey eye drops are used for dry eyes and blepharitis. Manuka honey has been proven to be useful for eczema, atopic dermatitis, wound healing, anti-bacterial, anti-parasitic and anti-inflammatory actions.

NCT ID: NCT03698045 Withdrawn - Clinical trials for Conjunctivitis, Bacterial

Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.

PRO-143
Start date: November 2013
Phase: Phase 1
Study type: Interventional

Study to evaluate the safety and tolerability of PRO-143 solution ophthalmic in healthy volunteers.

NCT ID: NCT03009799 Withdrawn - Clinical trials for Adenoviral Conjunctivitis

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)

Goldeneye
Start date: January 2017
Phase: Phase 2
Study type: Interventional

This clinical investigation aims at demonstrating that NCX-4240 is effective and safe in decreasing the number of days where adenoviral conjunctivis is detected in the eye and in reducing the duration and/or the severity of the signs and symptoms of adenoviral conjunctivis

NCT ID: NCT02795273 Withdrawn - Rhinitis Clinical Trials

Efficacy and Safety of Grass-SPIRE Registration Study

Start date: May 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of Grass-SPIRE compared with placebo and to evaluate the treatment effect of Grass-SPIRE on symptoms and use of rescue medication during the grass pollen season

NCT ID: NCT01721694 Withdrawn - Keratitis Clinical Trials

Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection

Start date: December 2012
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of fixed combination of azithromycin 1.5% + 0.5% Loteprednol eye drops for the treatment of ocular inflammation and infection associated bacterial blepharitis and / or keratitis and / or conjunctivitis compared with the individual administration of azithromycin 1.5% and 0.5% Loteprednol (separately).

NCT ID: NCT01657240 Withdrawn - Clinical trials for Allergic Conjunctivitis

Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis

Start date: November 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the clinical efficacy of the ophthalmic solution PRO-118 compared with olopatadine hydrochloride ophthalmic solution in allergic conjunctivitis.

NCT ID: NCT01541904 Withdrawn - Clinical trials for Conjunctivitis, Allergic

Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis

PRO-118
Start date: March 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of four doses of PRO-118 ophthalmic solution ophthalmic solution compared with placebo, for the treatment of seasonal (SAC) and perennial (PAC) allergic conjunctivitis.

NCT ID: NCT01238783 Withdrawn - Clinical trials for Bacterial Conjunctivitis

Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis

Start date: January 2011
Phase: Phase 2
Study type: Interventional

To assess safety and efficacy of AL-15469A 0.5% /AL-6515 0.3% Ophthalmic Suspension for treatment of bacterial conjunctivitis

NCT ID: NCT00881673 Withdrawn - Clinical trials for Allergic Conjunctivitis

To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge

Start date: May 2009
Phase: Phase 2
Study type: Interventional

The purpose of the study is to determine whether Al38583 Ophthalmic Solution is safe and effective in reducing tear eosinophil levels at 5-8 hours after Conjunctival Allergen Challenge (CAC).

NCT ID: NCT00754949 Withdrawn - Clinical trials for Blepharoconjunctivitis

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if AzaSite Plus is effective and safe for the treatment of blepharoconjunctivitis compared to AzaSite alone and Dexamethasone alone.